Professor Storey describes the earlier gaps in evidence due to low power studies which have now been addressed by the AUGUSTUS study.
Alternatively login via
Inflammatory bowel disease assessment tools
Hereditary ATTR amyloidosis
Optimising anti-TNF treatment using biosimilars
Chronic Lymphocytic Leukaemia (CLL)
Anticoagulation Therapy for Stroke Prevention
Back to epgonline.org